Literature DB >> 22375020

Demographics, clinical characteristics and outcomes of neonates diagnosed with fetomaternal haemorrhage.

Annemarie Stroustrup1, Leonardo Trasande.   

Abstract

OBJECTIVE: To determine clinical characteristics, demographics and short-term outcomes of neonates diagnosed with fetomaternal haemorrhage (FMH).
DESIGN: The authors analysed the Nationwide Inpatient Sample, 1993 to 2008. Singleton births diagnosed with FMH were identified by International Classification of Diseases (ICD-9) code 762.3. Descriptive, univariate and multivariable regression analyses were performed to determine the national annual incidence of FMH over time as well as demographics and clinical characteristics of neonates with FMH.
RESULTS: FMH was identified in 12 116 singleton births. Newborns with FMH required high intensity of care: 26.3% received mechanical ventilation, 22.4% received blood product transfusion and 27.8% underwent central line placement. Preterm birth (OR 3.7), placental abruption (OR 9.8) and umbilical cord anomaly (OR 11.4) were risk factors for FMH. Higher patient income was associated with increased likelihood of FMH diagnosis (OR 1.2), and Whites were more likely to be diagnosed than ethnic minorities (OR 1.9). There was reduced frequency of diagnosis in the Southern USA (OR 0.8 vs the Northeastern USA).
CONCLUSIONS: Diagnosis of FMH is associated with significant morbidity as well as regional, socioeconomic and racial disparity. Further study is needed to distinguish between diagnostic coding bias and true epidemiology of the disease. This is the first report of socioeconomic and racial/ethnic disparities in FMH, which may represent disparities in detection that require national attention.

Entities:  

Mesh:

Year:  2012        PMID: 22375020      PMCID: PMC3612974          DOI: 10.1136/archdischild-2011-300820

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  18 in total

1.  ACOG practice bulletin. Prevention of Rh D alloimmunization. Number 4, May 1999 (replaces educational bulletin Number 147, October 1990). Clinical management guidelines for obstetrician-gynecologists. American College of Obstetrics and Gynecology.

Authors: 
Journal:  Int J Gynaecol Obstet       Date:  1999-07       Impact factor: 3.561

2.  Chronic, massive fetomaternal hemorrhage treated with repeated fetal intravascular transfusions.

Authors:  R L Fischer; K Kuhlman; J Grover; O Montgomery; R J Wapner
Journal:  Am J Obstet Gynecol       Date:  1990-01       Impact factor: 8.661

3.  Fetomaternal transplacental hemorrhage during pregnancy and after delivery.

Authors:  J M Bowman; J M Pollock; L E Penston
Journal:  Vox Sang       Date:  1986       Impact factor: 2.144

Review 4.  Fetomaternal hemorrhage: incidence, risk factors, time of occurrence, and clinical effects.

Authors:  E S Sebring; H F Polesky
Journal:  Transfusion       Date:  1990-05       Impact factor: 3.157

5.  Massive fetomaternal hemorrhage and fetal death: are they predictable?

Authors:  R Samadi; J S Greenspoon; I Gviazda; R H Settlage; T M Goodwin
Journal:  J Perinatol       Date:  1999 Apr-May       Impact factor: 2.521

Review 6.  Severe fetomaternal hemorrhage: a review.

Authors:  G P Giacoia
Journal:  Obstet Gynecol Surv       Date:  1997-06       Impact factor: 2.347

7.  Large fetomaternal hemorrhage: clinical presentation and outcome.

Authors:  Z Kecskes
Journal:  J Matern Fetal Neonatal Med       Date:  2003-02

8.  Fetomaternal bleeding as a cause for "unexplained" fetal death.

Authors:  D W Laube; C W Schauberger
Journal:  Obstet Gynecol       Date:  1982-11       Impact factor: 7.661

9.  Massive fetomaternal hemorrhage: Manitoba experience.

Authors:  V de Almeida; J M Bowman
Journal:  Obstet Gynecol       Date:  1994-03       Impact factor: 7.661

10.  Risk factors for fetal-to-maternal transfusion in Rh D-negative women--results of a prospective study on 942 pregnant women.

Authors:  Matthias David; Julia Smidt; Frank C K Chen; Ursula Stein; Joachim W Dudenhausen
Journal:  J Perinat Med       Date:  2004       Impact factor: 1.901

View more
  6 in total

Review 1.  Maternal, Labor, Delivery, and Perinatal Outcomes Associated with Placental Abruption: A Systematic Review.

Authors:  Katheryne L Downes; Katherine L Grantz; Edmond D Shenassa
Journal:  Am J Perinatol       Date:  2017-03-22       Impact factor: 1.862

2.  Mild-to-moderate foeto-maternal haemorrhage in the third trimester and at term of pregnancy: quantitative determination and clinical-diagnostic evaluation.

Authors:  Fausta Beneventi; Chiara Cavagnoli; Elena Locatelli; Silvia Bariselli; Margherita Simonetta; Gianluca Viarengo; Cesare Perotti; Arsenio Spinillo
Journal:  Blood Transfus       Date:  2017-04-19       Impact factor: 3.443

3.  Demographic and Behavioral Predictors of Severe Fetomaternal Hemorrhage: A Case-Control Study.

Authors:  Annemarie Stroustrup; Callie Plafkin; Thuy-An Tran; David A Savitz
Journal:  Neonatology       Date:  2016-02-10       Impact factor: 4.035

4.  Impact of physician awareness on diagnosis of fetomaternal hemorrhage.

Authors:  Annemarie Stroustrup; Callie Plafkin; David A Savitz
Journal:  Neonatology       Date:  2014-02-08       Impact factor: 4.035

5.  A pilot prospective study of fetomaternal hemorrhage identified by anemia in asymptomatic neonates.

Authors:  A Stroustrup; C Plafkin
Journal:  J Perinatol       Date:  2016-01-14       Impact factor: 2.521

6.  Long-term persistent fetomaternal hemorrhage.

Authors:  Takeshi Umazume; Mamoru Morikawa; Takahiro Yamada; Kazutoshi Cho; Nobuo Masauzi; Hisanori Minakami
Journal:  Clin Case Rep       Date:  2015-09-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.